Records 1 - 3 (of 3 Records)
|Query Trace: Disease Progression and meta-analysis and ERCC1[original query]|
| No evidence of an association of ERCC1 and ERCC2 polymorphisms with clinical outcomes of platinum-based chemotherapies in non-small cell lung cancer: a meta-analysis.
Lung cancer (Amsterdam, Netherlands) 2011 Jun 72 (3): 370-7.
Yin Ming, Yan Jingrong, Voutsina Alexandra, Tibaldi Carmelo, Christiani David C, Heist Rebecca S, Rosell Rafael, Booton Richard, Wei Qing
| ERCC1 and ERCC2 polymorphisms predict clinical outcomes of oxaliplatin-based chemotherapies in gastric and colorectal cancer: a systemic review and meta-analysis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011 Mar 17 (6): 1632-40.
Yin Ming, Yan Jingrong, Martinez-Balibrea Eva, Graziano Francesco, Lenz Heinz-Josef, Kim Hyo-Jin, Robert Jacques, Im Seock-Ah, Wang Wei-Shu, Etienne-Grimaldi Marie-Christine, Wei Qing
| DNA repair gene ERCC1 polymorphisms may contribute to the risk of glioma.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2014 May 35 (5): 4267-75.
Yuan Guanqian, Gao Dandan, Ding Shaofeng, Tan J